Tscan Therapeutics Announces
Tscan Therapeutics Announces entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.
Timeline
Wed, 29 Jul 2026 11:00:00 GMTTScan Therapeutics Announces First Patient Dosed in Phase 3 - GlobeNewswire
Wed, 29 Jul 2026 07:00:00 GMTTScan’s Phase 3 Cancer Trial Enrolls Across U.S.; Data Expected 2028 - Stock Titan
Related explainers
HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.
Connected entities
Phase4 live mentionsCancer Trial Enrolls2 live mentionsAcross U2 live mentionsData Expected2 live mentionsFirst Patient Dosed1 live mentionsGlobeNewswire TScan Therapeutics1 live mentionsAnnounces First Patient1 live mentionsDosed1 live mentionsGlobeNewswire GlobeNewswire1 live mentionsTScan1 live mentions
FAQ
What does this page track?
Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tscan Therapeutics Announces.
Why might this page be noindex?
Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.
Where should readers verify facts?
Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.
Source diversity
2 distinct publisher/source names are currently connected to this entity page.